Epilizine Range 200 mg. 300 mg. 500 mg. 400 mg Prolonged Release Tablets
PDF Leaflet Revision Date: 13 May 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of epilepsy and manic episodes in bipolar disorder.
Dosage (summary)
Adults: Start at 600 mg/day, increase by 200 mg every 3 days; max 2500 mg/day. Children: 20-30 mg/kg/day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
High teratogenic risk; contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Carbapenem antibiotics
- Estrogen-containing products
- Phenobarbital
- Lamotrigine
Contraindications
- Hypersensitivity
- Pregnancy
- Active liver disease
- Mitochondrial disorders
Common side effects
- Tremor
- Somnolence
- Nausea
- Weight gain
Counselling Points
- Avoid alcohol
- Monitor for signs of liver damage
- Use effective contraception in women of childbearing potential
Serious warnings
- High teratogenic potential
- Risk of liver damage
- Suicidal ideation
Important Disclaimer
The Epilizine Range 200 mg. 300 mg. 500 mg. 400 mg Prolonged Release Tablets professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
